A 32-year-old man with schizophrenia has been on risperidone 6 mg daily for 8 months. He presents to the psychiatry clinic with complaints of difficulty in sexual performance and galactorrhea for the past 2 months. His wife reports he has gained 8 kg over this period. On examination, his blood pressure is 128/82 mmHg, heart rate 78/min. Prolactin level is 85 ng/mL (normal <25 ng/mL). What is the most likely mechanism underlying his sexual dysfunction?

Explanation

## Mechanism of Antipsychotic-Induced Sexual Dysfunction **Key Point:** Risperidone and other antipsychotics block dopamine D2 receptors in the tuberoinfundibular pathway, which normally inhibits prolactin release. This disinhibition causes hyperprolactinemia, leading to sexual dysfunction, galactorrhea, and gynecomastia. ### Dopamine and Prolactin Regulation Dopamine acts as prolactin-inhibiting factor (PIF) in the hypothalamic-pituitary axis. When D2 receptors are blocked: 1. Tonic dopamine inhibition is removed 2. Prolactin secretion from lactotroph cells increases unopposed 3. Elevated prolactin suppresses GnRH and gonadal hormone production 4. Sexual dysfunction, amenorrhea, and infertility result ### Clinical Features of Hyperprolactinemia | Feature | Mechanism | Timeline | |---------|-----------|----------| | Galactorrhea | Direct lactotroph stimulation | Weeks to months | | Sexual dysfunction | Suppressed gonadal hormones | Weeks to months | | Amenorrhea/oligomenorrhea | Suppressed GnRH and FSH/LH | Weeks to months | | Gynecomastia | Elevated prolactin + estrogen shift | Months | | Weight gain | Metabolic effects + appetite stimulation | Ongoing | **High-Yield:** Risperidone and paliperidone have the highest risk of hyperprolactinemia among antipsychotics because they have poor blood-brain barrier penetration and cause sustained D2 blockade in the tuberoinfundibular region. ### Risk Stratification by Antipsychotic **High prolactin risk:** Risperidone, paliperidone, amisulpride **Moderate risk:** Typical antipsychotics (haloperidol, chlorpromazine) **Low risk:** Aripiprazole (D2 partial agonist), quetiapine, clozapine **Clinical Pearl:** Aripiprazole can be used as an adjunct or switch agent to reverse antipsychotic-induced hyperprolactinemia because its partial agonist activity at D2 receptors actually lowers prolactin levels. **Warning:** Do not confuse alpha-1 blockade (causes orthostatic hypotension) or muscarinic blockade (causes anticholinergic effects) with prolactin-mediated sexual dysfunction. The elevated prolactin level in this case is diagnostic. ### Management Options 1. **Switch to low-prolactin antipsychotic** (aripiprazole, quetiapine, clozapine) 2. **Add dopamine agonist** (bromocriptine, cabergoline) — use cautiously in psychosis 3. **Dose reduction** if clinically feasible 4. **Augmentation with aripiprazole** (5–15 mg daily) [cite:Stahl's Essential Psychopharmacology 6e Ch 5]